Insilico Medicine Company

Insilico Medicine is an artificial intelligence company headquartered in Hong Kong, with R&D and management resources in the USA, Belgium, Russia, UK, Taiwan, and China sourced through hackathons and competitions. The company and its scientists are dedicated to extending human productive longevity and transforming every step of the drug discovery and drug development process through excellence in biomarker discovery, drug development, digital medicine, and aging research. In addition to working collaborations with the large pharmaceutical companies, the company is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging.


Technology: Machine Learning
Industry: Healthcare
Headquarters: Undisclosed
Founded Date: 2014
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 16
Total Funding: $51 300 000
Estimated Revenue: Less than $1M
Last Funding Date: 2020-04-20
Last Funding Type: Series B

Visit Website
Register and Claim Ownership